Federal Register / Vol. 83, No. 1 / Tuesday, January 2, 2018 / Notices 159 

Secretary with respect to: (1) The Site 

Exposure Matrices (SEM) of the 

Department of Labor; (2) medical 

guidance for claims examiners for 

claims with the EEOICPA program, with 

respect to the weighing of the medical 

evidence of claimants; (3) evidentiary 

requirements for claims under Part B of 

EEOICPA related to lung disease; and 

(4) the work of industrial hygienists and 

staff physicians and consulting 

physicians of the Department of Labor 

and reports of such hygienists and 

physicians to ensure quality, objectivity, 

and consistency. The Advisory Board 

sunsets on December 19, 2024. 

The Advisory Board operates in 

accordance with the Federal Advisory 

Committee Act (FACA) (5 U.S.C. App. 

2) and its implementing regulations (41 

CFR part 102–3). 

Agenda: The tentative agenda for the 

Advisory Board meeting includes: 

• Respond to the recommendation 

responses and requests for information 

provided by the program; 

• Discuss matters from SEM 

subcommittee meeting or other 

subcommittees; and 

• Administrative issues raised by 

Advisory Board functions and future 

Advisory Board activities. 

OWCP transcribes and prepares 

detailed minutes of Advisory Board 

meetings. OWCP will post the 

transcripts and minutes on the Advisory 

Board web page, http://www.dol.gov/ 

owcp/energy/regs/compliance/ 

AdvisoryBoard.htm, along with written 

comments, speaker presentations, and 

other materials submitted to the 

Advisory Board or presented at 

Advisory Board meetings. 

Public Participation, Submissions, and 

Access to the Public Record 

Advisory Board meetings: The 

Advisory Board will meet via 

teleconference on Tuesday, January 30, 

2018, from 1:00 p.m. to 5:00 p.m. 

Eastern time. All Advisory Board 

meetings are open to the public. The 

teleconference number and other details 

for listening to the meeting will be 

posted on the Advisory Board’s website 

no later than 72 hours prior to the 

meeting. This information will be 

posted at http://www.dol.gov/owcp/ 

energy/regs/compliance/ 

AdvisoryBoard.htm. 

Requests for special accommodations: 

Please submit requests for special 

accommodations to access the 

telephonic Advisory Board meeting by 

email, telephone, or hard copy to Ms. 

Carrie Rhoads, OWCP, Room S–3524, 

U.S. Department of Labor, 200 

Constitution Ave. NW, Washington, DC 

20210; telephone (202) 343–5580; email 

EnergyAdvisoryBoard@dol.gov. 

Submission of written comments for 

the record: You may submit written 

comments, identified as for the 

Advisory Board and the meeting date of 

June 19, 2017, by any of the following 

methods: 

• Electronically: Send to: 

EnergyAdvisoryBoard@dol.gov (specify 

in the email subject line, ‘‘Advisory 

Board Meeting January 30, 2018’’). 

• Mail, express delivery, hand 

delivery, messenger, or courier service: 

Submit one copy to the following 

address: U.S. Department of Labor, 

Office of Workers’ Compensation 

Programs, Advisory Board on Toxic 

Substances and Worker Health, Room 

S–3522, 200 Constitution Ave. NW, 

Washington, DC 20210. Due to securityrelated procedures, receipt of 

submissions by regular mail may 

experience significant delays. 

Comments must be received by 

January 23, 2018. OWCP will make 

available publically, without change, 

any written comments, including any 

personal information that you provide. 

Therefore, OWCP cautions interested 

parties against submitting personal 

information such as Social Security 

numbers and birthdates. 

Electronic copies of this Federal 

Register notice are available at http://

www.regulations.gov. This notice, as 

well as news releases and other relevant 

information, are also available on the 

Advisory Board’s web page at http://

www.dol.gov/owcp/energy/regs/ 

compliance/AdvisoryBoard.htm. 

FOR FURTHER INFORMATION CONTACT: You 

may contact Douglas Fitzgerald, 

Designated Federal Officer, at 

fitzgerald.douglas@dol.gov, or Carrie 

Rhoads, Alternate Designated Federal 

Officer, at rhoads.carrie@dol.gov, U.S. 

Department of Labor, 200 Constitution 

Avenue NW, Suite S–3524, Washington, 

DC 20210, telephone (202) 343–5580. 

This is not a toll-free number. 

Signed at Washington, DC, on December 

19, 2017. 

Julia K. Hearthway, 

Director, Office of Workers’ Compensation 

Programs. 

[FR Doc. 2017–28227 Filed 12–29–17; 8:45 am] 

BILLING CODE 4510–24–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2017–0215] 

Yttrium-90 Microsphere Brachytherapy 

Sources and Devices TheraSphere®

and SIR-Spheres®

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Draft guidance; extension of 

comment period. 

SUMMARY: On November 7, 2017, the 

U.S. Nuclear Regulatory Commission 

(NRC) solicited comments on its 

licensing guidance for licenses 

authorizing the use of Yttrium-90 (Y–90) 

Microsphere Brachytherapy Sources and 

Devices TheraSphere® and SIRSpheres®. The public comment period 

was originally scheduled to close on 

January 8, 2018. The NRC has decided 

to extend the public comment period to 

allow more time for members of the 

public to develop and submit their 

comments. 

DATES: The due date of comments 

requested in the document published on 

November 7, 2017 (82 FR 51655) is 

extended. Comments should be filed no 

later than February 8, 2018. Comments 

received after this date will be 

considered, if it is practical to do so, but 

the Commission is able to ensure 

consideration only for comments 

received on or before this date. 

ADDRESSES: You may submit comments 

by any of the following methods: 

• Federal Rulemaking website: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2017–0215. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–415–3463; 

email: Carol.Gallagher@nrc.gov. For 

technical questions, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

document. 

• Mail comments to: May Ma, Office 

of Administration, Mail Stop: OWFN–2– 

A13, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Dimmick, Office of Nuclear Material 

Safety and Safeguards, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001; telephone: 301–415– 

0694; email: Lisa.Dimmick@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2017– 

0215 when contacting the NRC about 


daltland on DSKBBV9HB2PROD with NOTICES
160 Federal Register / Vol. 83, No. 1 / Tuesday, January 2, 2018 / Notices 

the availability of information regarding 

this action. You may obtain publiclyavailable information related to this 

action by any of the following methods: 

• Federal rulemaking website: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2017–0215. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publiclyavailable documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The draft 

Y–90 Microsphere Brachytherapy 

Sources and Devices Licensing 

Guidance, Revision 10, is available in 

ADAMS under Accession No. 

ML17107A375. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

The draft Y–90 Microsphere 

Brachytherapy Sources and Devices 

Licensing Guidance, Revision 10, is also 

available on the NRC’s public website 

on the ‘‘Medical Uses Licensee Toolkit’’ 

page at https://www.nrc.gov/materials/ 

miau/med-use-toolkit.html. 

B. Submitting Comments 

Please include Docket ID NRC–2017– 

0215 in your comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at http://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

submissions to remove identifying or 

contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment submission into 

ADAMS. 

II. Discussion 

On November 7, 2017, the NRC 

solicited comments on its draft licensing 

guidance entitled ‘‘Yttrium-90 (Y–90) 

Microsphere Brachytherapy Sources and 

Devices TheraSphere® and SIRSpheres® Licensing Guidance.’’ This 

draft would be revision 10 to this 

licensing guidance. The licensing 

guidance for Y–90 microsphere 

brachytherapy was initially published 

in October 2002 and subsequently 

revised in 2004, 2007, 2008, 2011, 2012, 

and 2016. Following years of using the 

current licensing guidance, the NRC 

staff, stakeholders, and the Advisory 

Committee on the Medical Uses of 

Isotopes identified numerous issues that 

need to be addressed. A working group 

composed of Agreement State 

representatives and NRC staff was 

formed to address identified issues. This 

draft licensing guidance for Y–90 

microsphere brachytherapy has been 

revised to update criteria for training 

and experience, medical event 

reporting, inventory requirement 

specifications, and waste disposal 

issues. The draft guidance provides new 

information regarding cremation and 

autopsy. The public comment period 

was originally scheduled to close on 

January 8, 2018. The NRC has decided 

to extend the public comment period on 

this document until February 8, 2018, to 

allow more time for members of the 

public to submit their comments. 

Dated at Rockville, Maryland, this 27th day 

of December 2017. 

For the Nuclear Regulatory Commission. 

Kevin Williams, 

Deputy Director, Division of Material Safety, 

State, Tribal and Rulemaking Programs, 

Office of Nuclear Material Safety and 

Safeguards. 

[FR Doc. 2017–28271 Filed 12–29–17; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2017–0001] 

Sunshine Act Meeting Notice 

DATE: Weeks of January 1, 8, 15, 22, 29, 

February 5, 2018. 

PLACE: Commissioners’ Conference 

Room, 11555 Rockville Pike, Rockville, 

Maryland. 

STATUS: Public and Closed. 

Week of January 1, 2018 

There are no meetings scheduled for 

the week of January 1, 2018. 

Week of January 8, 2018—Tentative 

There are no meetings scheduled for 

the week of January 8, 2018. 

Week of January 15, 2018—Tentative 

Thursday, January 18, 2018 

9:00 a.m. Strategic Programmatic 

Overview of the Decommissioning 

and Low-Level Waste and Spent 

Fuel Storage and Transportation 

Business Lines (Public Meeting) 

(Contact: Damaris Marcano: 301– 

415–7328) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Week of January 22, 2018—Tentative 

Tuesday, January 23, 2018 

9:00 a.m. Hearing on Construction 

Permit for Northwest Medical 

Isotopes Production Facility: 

Section 189a of the Atomic Energy 

Act Proceeding (Public Meeting) 

(Contact: Michael Balazik: 301– 

415–2856) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Thursday, January 25, 2018 

10:00 a.m. Strategic Programmatic 

Overview of the New Reactors 

Business Line (Public Meeting) 

(Contact: Donna Williams: 301– 

415–1322) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Week of January 29, 2018—Tentative 

There are no meetings scheduled for 

the week of January 29, 2018. 

Week of February 5, 2018—Tentative 

Thursday, February 8, 2018 

9:00 a.m. Discussion of Potential 

Changes to the 10 CFR 2.206 

Enforcement Petition Process 

(Public Meeting) (Contact: Doug 

Broaddus: 301–415–8124) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

* * * * * 

The schedule for Commission 

meetings is subject to change on short 

notice. For more information or to verify 

the status of meetings, contact Denise 

McGovern at 301–415–0681 or via email 

at Denise.McGovern@nrc.gov. 

* * * * * 

The NRC Commission Meeting 

Schedule can be found on the internet 

at: http://www.nrc.gov/public-involve/ 

public-meetings/schedule.html. 

* * * * * 

The NRC provides reasonable 

accommodation to individuals with 

disabilities where appropriate. If you 

need a reasonable accommodation to 


daltland on DSKBBV9HB2PROD with NOTICES